郑州微飒生物科技有限责任公司 咨询热线：0371-88821766
行业动态

行业动态

追踪行业前沿，洞察产业趋势

药效评价Glycocluster design for improved avidity and selectivity in blocking human lectin/plant toxin binding to glycoproteins and cells.

期刊：Molecular pharmaceutics发表年份：2010作者：Sabine André; Martina Lahmann; Hans-Joachim Gabius; Stefan Oscarson
阅读更多 →

药效评价D-Maurocalcine, a pharmacologically inert efficient cell-penetrating peptide analogue.

期刊：The Journal of biological chemistry发表年份：2010作者：Cathy Poillot; Kaouthar Dridi; Hicham Bichraoui; Julien Pêcher; Sebastien Alphonse; Badreddine Douzi; Michel Ronjat; Hervé Darbon; Michel De Waard
阅读更多 →

药效评价Cationic amphiphilic polyproline helix P11LRR targets intracellular mitochondria.

期刊：Journal of controlled release : official journal of the Controlled Release Society发表年份：2010作者：Li Li; Iris Geisler; Jean Chmielewski; Ji-Xin Cheng
阅读更多 →

药效评价Spirocyclic ureas: orally bioavailable 11 beta-HSD1 inhibitors identified by computer-aided drug design.

期刊：Bioorganic & medicinal chemistry letters发表年份：2010作者：Colin M Tice; Wei Zhao; Zhenrong Xu; Salvacion T Cacatian; Robert D Simpson; Yuan-Jie Ye; Suresh B Singh; Brian M McKeever; Peter Lindblom; Joan Guo; Paula M Krosky; Barbara A Kruk; Jennifer Berbaum; Richard K Harrison; Judith J Johnson; Yuri Bukhtiy
阅读更多 →